Prosecution Insights
Last updated: November 04, 2026

Greyrock Technology LLC

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Greyrock Technology LLC currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This active matter is assigned to 1 distinct examiner and 1 distinct art unit. The data indicates that the company's current patent prosecution is concentrated in this single technical field, with no other active matters reported.

BRADY, KRISTEN WEEKS is the busiest examiner for the company, currently overseeing 1 pending office action. The presence of 1 distinct art unit shows that the company's pharmaceutical technology is being evaluated by a single specialized division. This individual handles the 1 pending office action for the portfolio.

For a practitioner, this concentration means that the prosecution strategy is focused on the 1 distinct examiner. There are no other active cases or different art units to coordinate, allowing for a direct approach. The company's immediate goals in Biotechnology & Pharmaceuticals are tied to the outcome of this single matter, making the interaction with the assigned examiner a primary focus.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BRADY, KRISTEN WEEKS 1 40.0% +0.0%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18445321 Process for the production of liquid fuels using biomass gasification integrated with an electrolyzer BRADY, KRISTEN WEEKS —

Top Art Units

Art UnitApps
1692 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18445321 Process for the production of liquid fuels using biomass gasification integrated with an electrolyzer BRADY, KRISTEN WEEKS 1692 §102§103§112 Non-Final OA — Pending Jul 10, 2023

Managing Greyrock Technology LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Greyrock Technology LLC have?

Greyrock Technology LLC has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Greyrock Technology LLC applications?

Kristen Weeks Brady has the most, with 1 of Greyrock Technology LLC's pending office actions.

What technology area are Greyrock Technology LLC's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month